Organon Co (OGN)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Dividendenhistorie

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Organon Co Stock (OGN) Company Profile

Healthcare (1124)

551-430-6000

30 HUDSON STREET, JERSEY CITY

Nächster Verdiensttermin

Neueste SEC-Einreichungen

OGN's Discussions on Twitter

Vergleichen Sie OGN mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
OGN Organon Co	7.18	1.81B	6.28B	700.00M	537.00M	2.6922
LLY Lilly Eli Co	993.64	879.11B	59.42B	18.41B	6.44B	20.22
JNJ Johnson Johnson	206.54	481.76B	92.15B	25.12B	20.46B	10.36
ABBV Abbvie Inc	225.18	394.11B	59.64B	2.36B	19.68B	1.3253
NVS Novartis Ag Adr	131.19	251.38B	54.45B	14.42B	17.15B	7.333
MRK Merck Co Inc	97.62	240.48B	63.90B	19.05B	13.05B	7.5596

Organon Co Stock (OGN) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-12-09	Eingeleitet	Barclays	Underweight
2025-10-27	Herabstufung	Piper Sandler	Overweight → Underweight
2025-05-02	Herabstufung	Evercore ISI	Outperform → In-line
2024-09-06	Herabstufung	JP Morgan	Neutral → Underweight
2023-11-03	Herabstufung	Goldman	Buy → Neutral
2023-09-21	Eingeleitet	Barclays	Overweight
2023-03-16	Eingeleitet	Raymond James	Outperform
2022-10-14	Herabstufung	BofA Securities	Neutral → Underperform
2022-09-06	Hochstufung	Piper Sandler	Neutral → Overweight
2022-08-05	Herabstufung	BofA Securities	Buy → Neutral
2022-04-27	Eingeleitet	Goldman	Buy
2022-04-06	Fortgesetzt	Morgan Stanley	Equal-Weight
2021-10-07	Eingeleitet	Piper Sandler	Neutral
2021-09-01	Eingeleitet	BofA Securities	Buy
2021-07-22	Eingeleitet	Citigroup	Buy
2021-06-15	Eingeleitet	JP Morgan	Neutral
2021-06-11	Eingeleitet	Morgan Stanley	Equal-Weight
2021-06-10	Eingeleitet	Evercore ISI	Outperform

Alle ansehen

Organon Co Aktie (OGN) Neueste Nachrichten

Finanzdaten der Organon Co-Aktie (OGN)

Organon Co (OGN)

Organon Co Stock (OGN) Company Profile

Vergleichen Sie OGN mit anderen Aktien

Organon Co Stock (OGN) Upgrades & Downgrades

Organon Co Aktie (OGN) Neueste Nachrichten

WHX Africa Leaders Summit: Organon Unveils Multi-Sector Approach to Women’s Health in Africa - News Ghana

Barclays Initiates Coverage of Organon (OGN) with Underweight Recommendation - Nasdaq

Why Organon (OGN) shares are trading lower today - MSN

Why Organon (OGN) Shares Are Trading Lower Today - The Globe and Mail

Organon (OGN) Receives New Coverage with 'Underweight' Rating fr - GuruFocus

Barclays Initiates Coverage on Organon & Co. (NYSE:OGN) - MarketBeat

Norges Bank Takes $19.78 Million Position in Organon & Co. $OGN - MarketBeat

Organon initiated with an Underweight at Barclays - TipRanks

American Century Companies Inc. Grows Position in Organon & Co. $OGN - MarketBeat

What analysts say about Organon Co stockFederal Reserve Announcements & Outstanding Growth Strategies - earlytimes.in

A Closer Look At Organon & Co.'s (NYSE:OGN) Impressive ROE - 富途牛牛

Can Organon (OGN) Turn Rising Investor Attention Into a Durable Reboot of Its Core Story? - simplywall.st

Organon & Co. (OGN) Stock Forecasts - Yahoo! Finance Canada

Co. (7XP) stock compared to peersPortfolio Update Report & Precise Buy Zone Identification - Newser

Organon & Co. $OGN Shares Acquired by Brandes Investment Partners LP - MarketBeat

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - MSN

Russell Investments Group Ltd. Has $15.96 Million Stock Position in Organon & Co. $OGN - MarketBeat

Can Organon’s (OGN) Biosimilar Push Transform Its Competitive Position in US Oncology? - Yahoo Finance

A Look at Organon's Valuation Following FDA Approval of First US Pertuzumab Biosimilar - Yahoo Finance

Is Organon’s Recent 14% Price Jump Justified After Women’s Health Partnership News? - Yahoo Finance

What analysts say about Organon Co 7XP stockShort Interest Overview & Grow Steadily With Our Wealth Roadmap - earlytimes.in

Organon (OGN): Buy, Sell, or Hold Post Q3 Earnings? - The Globe and Mail

Grantham Mayo Van Otterloo & Co. LLC Buys 108,429 Shares of Organon & Co. $OGN - MarketBeat

Avoiding Lag: Real-Time Signals in (OGN) Movement - news.stocktradersdaily.com

Organon (OGN): Exploring Valuation Following FDA Approval of First US Pertuzumab Biosimilar - simplywall.st

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review

Organon & Co. $OGN Shares Sold by Envestnet Asset Management Inc. - MarketBeat

Organon & Co. (OGN) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review

Creative Planning Buys 97,429 Shares of Organon & Co. $OGN - MarketBeat

Advisors Asset Management Inc. Sells 64,625 Shares of Organon & Co. $OGN - MarketBeat

Is Organon Co 7XP a good long term investmentLong-Term Investment Plans & High Yield Investment Portfolio - earlytimes.in

Organon & Co. $OGN Shares Sold by Geode Capital Management LLC - MarketBeat

Q3 Rundown: Organon (NYSE:OGN) Vs Other Branded Pharmaceuticals Stocks - The Globe and Mail

EXTENDED CLASS PERIOD: Organon & Co. (OGN) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit (PR Newswire) - Aktiellt

TUESDAY INVESTOR DEADLINE: Organon & Co. (OGN) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit (PR Newswire) - Aktiellt

Congressional Trading Report: Sen. Gary C Peters Sold Over $1K In Organon Stock - Benzinga

Organon (NYSE: OGN) leaders to speak at Piper Sandler 37th Annual Healthcare Conference - Stock Titan

Organon To Present at the Piper Sandler 37th Annual Healthcare Conference - Barchart.com

Organon & Co.Gary C. Peters Congressional Trade on Jul. 10, 2025 - Quiver Quantitative

Organon’s Deep Discount Comes With a Heavy Dose of Risk - Finimize

Can OGN’s First US Biosimilar Approval Redefine Its Long-Term Oncology Strategy? - Sahm

Organon and QC LGU empower women to ‘Take Control’ on World Contraception Day - Inquirer.net

Organon announces departure of chief commercial officer - MSN

Kingsview Wealth Management LLC Acquires New Position in Organon & Co. $OGN - MarketBeat

130,136 Shares in Organon & Co. $OGN Acquired by Neo Ivy Capital Management - MarketBeat

Co. (7XP) stock profit from AI boomChart Signals & Consistent Profit Alerts - newser.com

Discipline and Rules-Based Execution in OGN Response - news.stocktradersdaily.com

Henlius, Organon win US FDA approval of first Perjeta biosimilar - BioWorld MedTech

Co. (7XP) stock profit from automation waveWeekly Trade Recap & Fast Gain Swing Alerts - newser.com

Organon Executive Chairman of the Board Acquires 525% More Stock - simplywall.st

Finanzdaten der Organon Co-Aktie (OGN)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie OGN